Description
| What It Is | PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist structurally derived from melanotan-class peptides and studied in laboratory models of melanocortin receptor signaling. |
| What It’s Derived From | PT-141 is derived from modified analogues of α-melanocyte–stimulating hormone (α-MSH), including melanotan II–related sequences, and is engineered to act on melanocortin receptor subtypes with defined receptor selectivity. |
| What Research Focuses On | Research evaluates PT-141 in in vitro and preclinical models examining melanocortin receptor (MC3R and MC4R) activation, ligand–receptor selectivity, GPCR-mediated second-messenger signaling cascades, and neuroendocrine pathway mapping under controlled experimental conditions. |





Reviews
There are no reviews yet.